Adverum Biotechnologies Inc (0HA3)
LSE
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 1.46M | 1.85M | 1.61M | 250k | 0 | 7.5M | 0 | 3.6M |
営業利益 | -115.28M | -58.85M | -78.08M | -68.55M | -117.95M | -146.12M | -157.14M | -123.99M |
税引前収入 | -114.52M | -56.15M | -73.88M | -64.49M | -116.39M | -145.54M | -154.46M | -118.24M |
純利益 | -113.75M | -56.15M | -72.63M | -64.49M | -117.51M | -145.54M | -154.54M | -117.17M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.721 | -1.146 | -1.153 | -0.958 | -1.205 | -1.479 | -1.55 | -1.16 |
EBIT | -114.52M | -56.15M | -73.88M | -64.49M | -116.39M | -145.54M | -154.46M | -118.24M |
EBITDA | -52.97M | -56.75M | -71.33M | -66.97M | -113.79M | -141.48M | -150.61M | -118.35M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約